In the title compound, C 13 H 10 FNOS 2 , the sulfanylidenethiazolidine ring and the benzylidene ring are almost coplanar [dihedral angle between the two planes = 0.1 (2) ]. The mean plane through the allyl group is nearly perpendicular to the sulfanylidenethiazolidine ring, as indicated by the dihedral angle of 69.5 (5) between them. In the crystal, molecules are linked together by weak C-HÁ Á ÁO hydrogen bonds involving the same acceptor atom, forming dimers parallel to (122).
Structure description
5-Arylidene-2-sulfanylidene-1,3-thiazolidinine-4-ones or 5-arylidene rhodanines are considered to be 'privileged scaffolds' in the medicinal chemistry community because they present bioactivity in a large range of derivatives (Mendgen et al., 2012; Khazaei et al., 2014; Coulibaly et al., 2015; Tomasić & Masic et al., 2009) . For example, these small molecules have been known to possess a wide range of biological properties such as potent and selective inhibitors of the 'atypical' dual-specificity phosphatase (DSP) family member-JNK-stimulating phosphatase-1 (JSP-1) (Cutshall et al., 2005) , as aldose reductase inhibitors in diabetic peripheral neuropathy (Hotta et al., 2006) , and as DDX3 inhibitors for HIV replication (Maga et al., 2008) . The unusual biological activities displayed by many rhodanine-based molecules have made them attractive synthetic targets.
The molecule of the title compound is build up from a 4-fluorobenzylidene ring linked to a sulfanylidenethiazolidine ring which is attached to an allyl group as shown in Fig. 1 . The 4-fluorobenzylidene and the sulfanylidenethiazolidine rings are virtually coplanar with a maximum deviation from the mean plane of 0.067 (3) Å for the C4 atom. The data reports sulfanylidenethiazolidine ring makes a dihedral angle of 69.5 (5) with the plan through the allyl group.
Structure cohesion is ensured by weak C3-H3Á Á ÁO1 and C7-H7Á Á ÁO1 hydrogen bonds, forming dimers parallel to (122) (see Fig. 2 and Table 1 ).
Synthesis and crystallization
To a solution of 3-allylrhodanine (1.15 mmol, 0.2 g) in 10 ml of THF, (4-fluorobenzylidene)-4-methyl-5-oxopyrazolidin-2ium-1-ide (1.38 mmol) was added. The mixture was refluxed for 8 h, monitored by TLC, the reaction completed and a yellow spot (TLC R f = 0.3, using hexane/ethyl acetate 1:9) was generated cleanly. The solvent was evaporated in vacuo. The crude product was purified on silica gel using hexane:ethyl acetate (1:9) as eluent. The title compound was recrystallized from ethanol solution (yield 82%, m.p. 382 K).
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 .
Figure 2
Crystal packing for the title compound showing hydrogen bonds as dashed lines. Table 1 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) Àx; Ày; Àz þ 1. Computer programs: APEX2 and SAINT (Bruker, 2009) , SHELXT (Sheldrick, 2015a), SHELXL2014 (Sheldrick, 2015b), ORTEPIII (Burnett & Johnson, 1996) , ORTEP-3 for Windows (Farrugia, 2012) , PLATON (Spek, 2009) and publCIF (Westrip, 2010).
Figure 1
Plot of the molecule of the title compound with the atom-labelling scheme. 
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
data-2
IUCrData (2016). 1, x161236 Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) (4) 
